- Home
- ANSC vs LAB Comparison
ANSC vs LAB Comparison
Compare ANSC & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANSC
- LAB
- Stock Information
- Founded
- ANSC 2021
- LAB 1999
- Country
- ANSC United States
- LAB United States
- Employees
- ANSC N/A
- LAB N/A
- Industry
- ANSC
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- ANSC
- LAB Industrials
- Exchange
- ANSC Nasdaq
- LAB Nasdaq
- Market Cap
- ANSC 466.6M
- LAB 449.9M
- IPO Year
- ANSC 2023
- LAB 2011
- Fundamental
- Price
- ANSC $11.10
- LAB $1.43
- Analyst Decision
- ANSC
- LAB Hold
- Analyst Count
- ANSC 0
- LAB 2
- Target Price
- ANSC N/A
- LAB $1.35
- AVG Volume (30 Days)
- ANSC 229.8K
- LAB 2.2M
- Earning Date
- ANSC 01-01-0001
- LAB 11-04-2025
- Dividend Yield
- ANSC N/A
- LAB N/A
- EPS Growth
- ANSC N/A
- LAB N/A
- EPS
- ANSC 0.20
- LAB N/A
- Revenue
- ANSC N/A
- LAB $169,737,000.00
- Revenue This Year
- ANSC N/A
- LAB N/A
- Revenue Next Year
- ANSC N/A
- LAB N/A
- P/E Ratio
- ANSC $54.63
- LAB N/A
- Revenue Growth
- ANSC N/A
- LAB 79.77
- 52 Week Low
- ANSC $10.42
- LAB $0.92
- 52 Week High
- ANSC $11.14
- LAB $2.25
- Technical
- Relative Strength Index (RSI)
- ANSC 62.98
- LAB 66.08
- Support Level
- ANSC $11.03
- LAB $1.28
- Resistance Level
- ANSC $11.10
- LAB $1.46
- Average True Range (ATR)
- ANSC 0.03
- LAB 0.08
- MACD
- ANSC 0.00
- LAB 0.03
- Stochastic Oscillator
- ANSC 81.82
- LAB 91.03
About ANSC Agriculture & Natural Solutions Acquisition Corporation
Agriculture & Natural Solutions Acquisition Corp is a blank check company.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.